Gains:
- Ability to understand that the majority of laboratory errors occur in the pre-analytical phase and use artificial intelligence in sample suitability control.
- Ability to interpret HIL indices (hemolysis, icterus, lipemia) and how interference affects which tests
- Ability to take the artificial intelligence's sample rejection/acceptance recommendation as a draft and verify the final decision with laboratory rules
When discussing laboratory errors, most people blame the equipment and measurement. However, there is a fact that has been repeated for decades: the vast majority of laboratory errors do not occur in the device (analytical phase), but before the sample enters the device, that is, in the pre-analytical phase. Blood taken from the wrong patient, sample placed in the wrong tube, insufficient volume, long waiting, cells ruptured by shaking—none of these are the fault of the device, but they all distort the result. The most insidious part is this: a sample with pre-analytical error is measured perfectly in the instrument and produces a “clean” number; That number is wrong, but it is not obvious that it is wrong. Therefore, the pre-analytical phase is the first and most important line of defense for patient safety.
Why pre-analytical errors are so common in this unit; the main interferences that deteriorate sample quality—especially HIL indices (hemolysis, icterus, lipemia)—and how they affect which tests; and how to safely use AI in sample suitability control. Basic principle: AI scans sample suitability and produces a rejection/acceptance draft; The final decision is made by an expert, according to laboratory rules.
Why errors are concentrated in the pre-analytical phase
The pre-analytical phase is the phase where the most human hands and the most variables come into play. Major sources of errors:
- Patient and sample identification: Labeling the wrong patient is the most dangerous mistake; another's result is attributed to a patient.
- Wrong tube: Each tube has a different additive (anticoagulant or gel) in it. EDTA tube binds potassium and lowers calcium; Choosing the wrong tube radically distorts the result.
- Insufficient/excess volume: If the anticoagulant-blood ratio is disrupted, clotting tests (coagulation) will be incorrect.
- Hemolysis: The bloodletting technique, using a fine needle, harsh aspiration, or shaking, breaks down red blood cells.
- Waiting and storage: In a long-waiting sample, glucose decreases and potassium increases; Bilirubin left in the light is degraded.
- IV line contamination: Blood taken from the arm receiving fluid mixes with the components of that fluid.
The common feature of these errors is that the device may not be able to see them. Tools such as delta check and HIL indexes catch some pre-analytical errors, but most are avoided through a careful acceptance process.
HIL indices: hemolysis, icterus, lipemia
Modern biochemistry analyzers measure the color and turbidity of the serum and numerically report three interferences: HIL indices.
- Hemolysis (H): The breakdown of red blood cells and the mixing of their contents into the serum; serum appears pink-red. It falsely increases the substances (potassium, LDH, AST) that are concentrated in the cell.
- Icterus (I): Yellow-orange appearance of the serum due to high bilirubin; biases measurement in some colorometric tests.
- Lipemia (L): It is a cloudy/milky appearance due to high fat (triglycerides) in the serum; It interferes with many tests by impairing light transmission and may show falsely low levels of some electrolytes.
The following table summarizes the effects of HIL interferences on some tests (effects vary by method; refer to your specific device's package insert):
interference
Can raise fake
Can drop fake
typical sign
Hemolysis (H)
Potassium, LDH, AST, iron
haptoglobin (in some tests)
Pink-red serum
Icterus (I)
(depending on method)
Some colorometric tests
Yellow-orange serum
Lipemia (L)
(due to blur)
Sodium (in some methods)
Milky, cloudy serum
Critical point: HIL interference affects not only the appearance of the sample but also the accuracy of the result. A potassium reading of 6.5 mmol/L in a hemolyzed sample may be a false elevation and not true hyperkalemia (see Unit 4).
Caution: Releasing a sample with a high interference index by saying "the result is out, let's send it" means reporting a false result as if it were correct. Analytes affected by interference are either confirmed with a new sample or reported with an interference note using the appropriate method.
How AI helps with sample compliance
AI is valuable as a scanner and mnemonic in pre-analytical control. It can evaluate HIL indices on a test-by-test basis and generate warnings such as "the level of hemolysis in this sample affects the potassium result, verification required"; may flag a prompt-tube mismatch; may submit an outline based on laboratory rules for the rejection/accept decision; May prepare feedback summary to staff to improve sample quality (blood collection technique, handling time). But the rejection and acceptance decision is made by the expert according to your laboratory's approved sample acceptance-rejection criteria; AI's proposal is a draft.
Weak prompt / Strong prompt
Weak prompt:
Is this sample good, should we send the results? I think there is hemolysis.
This claim does not quantify the hemolysis index, does not include which tests were run, and does not include laboratory criteria. AI gives a general answer; It cannot clarify which analyte is affected and what to do.
Powerful prompt:
Your role: assistant to laboratory specialist preparing sample suitability assessment DRAFT. The decision is mine. Sample: serum. HIL indices:hemolysis 3+ (high), icterus normal, lipemia normal. Tests studied: potassium, sodium, AST, ALT, creatinine, LDH. Task: (1) mark which tests are affected by this level of hemolysis, (2) suggest "new sample / report with interference note / not affected" for each affected test, (3) specify the unaffected tests separately. Also write down which thresholds I should look at to finalize my laboratory rejection criteria. Prepare a draft so that I can make a final decision.
The strong prompt gives the HIL indexes numerically, includes the test list, asks for test-by-test recommendations, and leaves the decision to the expert.
three mini cases
Case 1 — Correct sorting. One sample showed hemolysis 3+ and the tests studied included potassium, LDH, AST. AI produces draft "these three tests are significantly affected by hemolysis, new sample is recommended; creatinine and sodium are less affected by this level". The specialist checks the laboratory criteria, requests a new sample for potassium/LDH/AST, and reports the others with an interference note. False reporting of hyperkalemia is prevented.
Case 2 — Incorrect tube capture. The blood volume in the incoming tube for a coagulation test is below the marker line. In the request-tube-volume control, AI warns "citrate tube insufficient volume, anticoagulant-blood ratio is impaired, INR/aPTT is unreliable". The expert rejects the sample and requests a new sample. An incorrect clotting result and possible incorrect drug dose are prevented. Lesson: volume ratio is critical in coagulation.
Case 3 — Lipemia trap. The sample from a fed patient is markedly lipemic. YZ reminds that lipemia can cause spurious low sodium in some electrolyte methods. The specialist checks whether the result is affected by the laboratory method and, if necessary, confirms it with a fasting sample or the appropriate method. Lesson: interference depends on the method; The reminder is important, but the decision is made in your own way.
Copiable prompt templates
SAMPLE COMPLIANCE ASSESSMENT TEMPLATEsample type: [serum/plasma/whole blood]. HIL indices: hemolysis [x],icterus [x], lipemia [x]. Tests run: [list]. For each test, mark whether it is affected by interference and suggest "new sample / report with interference note / not affected". The decision is mine; Also write down the thresholds at which I will clarify my retcriteria.
CLAIM-TUBE COMPATIBILITY CHECK TEMPLATEThere are the following test orders and corresponding tube types/volumes. Check if the correct tube and sufficient volume are used for each order; If there is any incompatibility, check "[rejection candidate - reason]". Check the volume ratio especially for coagulation. Data: [list].
PRE-ANALYTICAL ERROR CLASSIFICATION TEMPLATE Categorize the rejection reasons for the following rejected samples (identity, wrong tube, hemolysis, insufficient volume, clot, handling/holding). Indicate the most common category and recommendation for improvement. This is a quality improvement summary; It does not contain personal/patient information. Data: [list].
BLOOD DRAWING FEEDBACK TEMPLATEHemolysis rate is high in a particular unit. Draft a training note outlining possible causes of blood collection and handling (needle diameter, aspiration, shaking, handling time, temperature) and corrective suggestions. Use constructive, not accusatory language.
Common mistakes
- Thinking that interference is just color. HIL corrupts the accuracy of the result; not reported until the affected analyte is verified.
- Mistaking high potassium in a hemolyzed sample as real. Spurious hyperkalemia is the most classic pre-analytical trap.
- Skipping the volume ratio in coagulation. Insufficient citrate tube makes INR/aPTT unreliable.
- Not questioning the sample taken from the IV line. Liquid contamination radically distorts the results.
- Mistaking an AI rejection suggestion for a decision. Rejection/acceptance is given expertly according to the laboratory's approved criteria.
Tip: Make two questions a reflex with every sample: “Was this sample collected in the right way, from the right patient, in the right tube?” and “Which test does interference (HIL) affect?” Your pre-analytical attention determines the accuracy of all subsequent stages.
In summary
Most laboratory errors occur in the pre-analytical phase, before the sample enters the device, and these errors are measured perfectly in the device, producing a "clean but wrong" result. Identity, tube type, volume, hemolysis, retention, and contamination are the primary sources. HIL indices (hemolysis, icterus, lipemia) spuriously elevate or lower certain tests; affected analytes are not reported without verification. Artificial intelligence can scan sample suitability, flag interference and non-compliance, and produce a rejection/acceptance draft; but the final decision is made expertly according to your laboratory's approved criteria. Pre-analytical attention is the first line of defense for patient safety.
Application task
Construct a sample scenario (with HIL indexes and list of tests run) and receive a test-by-test outline from the AI with the "Sample Suitability Assessment" template. For each affected test, justify your decision based on your laboratory's rejection criteria. Then categorize a list of rejected samples with the "Pre-Analytical Error Classification" template to identify the most common cause and a recommendation for improvement.
checklist
- [ ] I checked sample ID, tube type and volume suitability.
- [ ] I evaluated HIL indexes on a test basis.
- [ ] I did not report analytes affected by interference without verification.
- [ ] I checked the volume/anticoagulant ratio in the coagulation samples.
- [ ] I made the rejection/accept decision based on my laboratory's approved criteria.
- [ ] I prepared an improvement summary for recurring problems such as high hemolysis.